simvastatin has been researched along with Chronic Hepatitis C in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Goel, A; Lavezo, J; Podboy, A; Wong, K | 1 |
| Abufreha, N; Dahari, H; Dizengof, V; Etzion, O; Nevo-Shor, A; Yardeni, D | 1 |
| Ampuero, J; Del Campo, JA; Gallego, P; Gallego-Durán, R; García-Valdecasas, M; Gil-Gómez, A; Grande, L; Muntané, J; Padillo, FJ; Pastor, H; Rojas, Á; Romero-Gómez, M | 1 |
| Pariente, A | 1 |
| Fine, E; Heffner, R; Supala-Berger, A; Young-McLain, E | 1 |
| Altmeyer, R; Cheng, CW; Chopra, N; Lawitz, E; Lim, SG; McHutchison, JG; Patel, K; Randle, JC; Tillmann, HL | 1 |
| Gibson, K; Rindone, JP | 1 |
1 trial(s) available for simvastatin and Chronic Hepatitis C
| Article | Year |
|---|---|
Open-label phase 1b pilot study to assess the antiviral efficacy of simvastatin combined with sertraline in chronic hepatitis C patients.
Topics: Adult; Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Hypolipidemic Agents; Interferon-alpha; Male; Middle Aged; Pilot Projects; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Selective Serotonin Reuptake Inhibitors; Sertraline; Simvastatin; Singapore; United States | 2011 |
6 other study(ies) available for simvastatin and Chronic Hepatitis C
| Article | Year |
|---|---|
Dead Meat: Glecaprevir/Pibrentasvir-Induced Statin Myonecrosis.
Topics: Antiviral Agents; Benzimidazoles; Biopsy; Coronary Artery Disease; Drug Combinations; Drug Interactions; Hepatitis C, Chronic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver Cirrhosis; Male; Middle Aged; Myalgia; Pyrrolidines; Quinoxalines; Rhabdomyolysis; Simvastatin; Sulfonamides | 2020 |
Sustained virological response following an 11-day course of direct acting antiviral therapy for hepatitis C infection.
Topics: 2-Naphthylamine; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Cytochrome P-450 CYP3A Inhibitors; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lactams, Macrocyclic; Middle Aged; Proline; Ritonavir; Simvastatin; Sulfonamides; Sustained Virologic Response; Uracil; Valine | 2020 |
Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy.
Topics: Autophagy; Biomarkers, Tumor; Carcinoma, Hepatocellular; Caspase 3; Cell Line; Cell Proliferation; Cells, Cultured; Drug Therapy, Combination; Gene Expression; Hepacivirus; Hepatitis C, Chronic; Hepatocytes; Humans; Liver Neoplasms; Metformin; Microtubule-Associated Proteins; PTEN Phosphohydrolase; Simvastatin; TOR Serine-Threonine Kinases; Tumor Protein, Translationally-Controlled 1 | 2018 |
[Statin against cirrhosis].
Topics: Adenoviridae; Animals; Cells, Cultured; Disease Models, Animal; Gene Knockout Techniques; Genetic Vectors; Hepatitis C, Chronic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kruppel-Like Transcription Factors; Liver Cirrhosis; Nitric Oxide; Rats; Simvastatin | 2015 |
Hyaline inclusion myopathy: unmasked by statin therapy.
Topics: Alcoholism; Electromyography; Electrophysiology; Hepatitis C, Chronic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertriglyceridemia; Interferons; Male; Microscopy, Electron; Middle Aged; Muscle Weakness; Muscle, Skeletal; Myositis, Inclusion Body; Simvastatin | 2009 |
Experience with statin use in patients with chronic hepatitis C infection.
Topics: Aged; Alanine Transaminase; Anticholesteremic Agents; Aspartate Aminotransferases; Biomarkers; Cholesterol; Hepatitis C, Chronic; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Prevalence; Simvastatin; Treatment Outcome; United States | 2005 |